Pei Wan

442 citations
16 papers · 311 indexed · h-index 10
Topics
Ferroptosis and cancer prognosis (3 papers)Beetle Biology and Toxicology Studies (2 papers)Renal cell carcinoma treatment (2 papers)
Partner nations
ChinaHong KongFinland

In The Last Decade

Pei Wan

15 papers receiving 307 citations

Peers

Pei Wan
Comparison fields: 5 of 62
  • Molecular Biology 107
  • Epidemiology 90
  • Infectious Diseases 84
  • Cancer Research 78
  • Pulmonary and Respiratory Medicine 52
Replace Reza Taslimi with:
Reza Taslimi Iran
Mai Thanh Binh Vietnam
Ruth Drury United Kingdom
Espérance Mukawera Canada
Rentao Yu China
Alexandra E. Livanos United States
Jamal Zaini Indonesia
Sabine Kendl Germany
Dariusz Bielicki Poland
Chakib Boussahmain United States
Pei Wan relative to Reza Taslimi Iran Reza Taslimi's profile →
Citations per field
00.5×
Reza Taslimi · 1×
Citations per year

Countries citing papers authored by Pei Wan

Since Specialization
Citations

This map shows the geographic impact of Pei Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei Wan more than expected).

Fields of papers citing papers by Pei Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pei Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei Wan. The network helps show where Pei Wan may publish in the future.

Co-authorship network of co-authors of Pei Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Pei Wan. A scholar is included among the top collaborators of Pei Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pei Wan. Pei Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 0
2 1
3 10
4 24
5 6
6 5
7 22
8 13
9 13
10 14
11 14
12 33
13
[Construction of a recombinant lentiviral vector of p38 MAPK and establishment of a human prostatic carcinoma cell line stably expressing p38 MAPK].
1
14 9
15 49
16 97

About Pei Wan

Pei Wan is a scholar working on Cancer Research, Toxicology and Biotechnology, having authored 16 papers that have together received 311 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (3 papers), Beetle Biology and Toxicology Studies (2 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Cancer Research (78 citations), Infectious Diseases (84 citations) and Epidemiology (90 citations). Pei Wan has collaborated with scholars based in China, Hong Kong and Finland. Frequent co-authors include Huiming Jiang, Nanhui Chen, Haibin Chen, J. L. Jones, Debra L. Hanson, R. Monina Klevens, Mark S. Dworkin, Patrick S. Sullivan, Wanlong Tan and You Zhou. Their work appears in journals such as Clinical Infectious Diseases, BioMed Research International and Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026